Medicinova (MNOV) Other financing activities (2014 - 2021)
Medicinova (MNOV) posted quarterly Other financing activities of $6110.0 for Q1 2021, down 2.3% year-over-year from $6254.0 in Q1 2020, and up 12.03% quarter-over-quarter from $5454.0 in Q3 2020.
Medicinova (MNOV) Other financing activities (2014 - 2021) Analysis & Trends
Medicinova (MNOV) has reported Other financing activities for 8 consecutive years, with $6110.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Other financing activities fell 2.3% year-over-year to $6110.0; the TTM figure through Dec 2021 stood at $6110.0 (down 47.81% YoY), while the FY2021 annual figure was $6110.0, down 47.81% from the prior year.
- Other financing activities climbed to $6110.0 in Q1 2021 per MNOV's latest filing, from $5454.0 in the prior quarter.
- Across five years, Other financing activities topped out at $65025.0 in Q1 2017 and bottomed at -$1.0 in Q4 2018.
- Historically, Other financing activities has averaged $15769.6 across 5 years, with a median of $10417.0 in 2019.
- Annual changes were most pronounced in 2017 — Other financing activities plunged 67.48% — and 2018, when it soared 87.96%.
- Medicinova's Other financing activities stood at $12294.0 in 2017, then slumped by 100.01% to -$1.0 in 2018, then soared by 1041800.0% to $10417.0 in 2019, then tumbled by 47.64% to $5454.0 in 2020, then advanced by 12.03% to $6110.0 in 2021.
- Business Quant data shows MNOV's Other financing activities at $6110.0 in Q1 2021, $5454.0 in Q3 2020, and $6254.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 6,110.00 |
| Mar 31, 2021 | 6,110.00 |
| Sep 30, 2020 | 5,454.00 |
| Sep 30, 2020 | 5,454.00 |
| Mar 31, 2020 | 6,254.00 |
| Mar 31, 2020 | 6,254.00 |
| Sep 30, 2019 | 10,417.00 |
| Sep 30, 2019 | 10,417.00 |
| Mar 31, 2019 | 16,903.00 |
| Mar 31, 2019 | 16,903.00 |
| Dec 31, 2018 | -1.00 |
| Dec 31, 2018 | -1.00 |
| Sep 30, 2018 | 23,108.00 |
| Sep 30, 2018 | 23,108.00 |
| Jun 30, 2018 | 1.00 |
| Jun 30, 2018 | 1.00 |
| Mar 31, 2018 | 27,901.00 |
| Mar 31, 2018 | 27,901.00 |
| Sep 30, 2017 | 12,294.00 |
| Sep 30, 2017 | 12,294.00 |